Biotesting Center

The Biotesting Center is a facility funded by the National Institutes of Health where antibacterial, antiviral and cytotoxic bioassays of novel compounds, natural or synthetic, are conducted. Extracts of intact biological systems are also performed. Cytotoxic assays currently available are against a series of human tumoral cell lines: small cell lung carcinoma, monocytic leukemia, promelocytic leukemia and epidermoid carcinoma, among others. This research activity provides the infrastructure for an investigator-based network of collaborative efforts aimed at the identification of bioactive substances. Under development at present is a series of target-oriented bioassays that will provide the basis for studying the action mechanism of these novel drugs.

For additional iinformation, please contact Dr. Fernando A. González.